While the binding sites of GR and AR in prostate cancer cells exhibit clear overlap, there seems to be a difference in the composition of enriched motifs: FOXA1 motif enrichment is more prevalent in AR binding sites, whereas ETS family motif enrichment is more prevalent in GR binding sites (89). The gene discussed is NR3C1; the disease is prostate carcinoma.